| Application no. and date | 13764989.3 (espacenet) (Federated) (European Patent Register), 20130315 | | Patent/reg. no. and date | DK/EP 2827862, 20231227 | | Publication date | 20150128 | | Priority no. and date | US 201261613173 P, 20120320, US 201261669889 P, 20120710 | | EP pub. no. and date |
EP 2827862 20150128 | | Effective date | | | Applicant/owner | Eagle Pharmaceuticals, Inc., 50 Tice Boulevard
Suite 315
Woodcliff Lake, NJ 07677, US | | Applicant ref. no. | P83742DK01 | | Inventor | SUNDARAM, Srikanth, 138 Emerson Road
Somerset, New Jersey 08873, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/4184 (2006.01) , A61K 47/10 (2017.01) , A61K 47/20 (2006.01) , A61K 9/00 (2006.01) | | Title | FORMULERINGER AF BENDAMUSTIN | | Int. application no. | US2013032289 | | Int. publication no. | WO2013142358 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
